Boca Raton, FL, United States
Boca Raton, FL, United States

Time filter

Source Type

Trademark
Cogint Inc. and IDI Inc | Date: 2016-07-07

Computer software for use in business and consumer applications for risk management and consumer marketing, namely, for use in information and database management, information processing, compiling marketing demographics and information for online and performance-based advertising and marketing services, lead generation and customer acquisition, and collection, structuring, fusing, storing and sharing of data and information with governmental, business and other organizations for risk management. Online advertising and marketing services; performance-based online and mobile advertising and marketing services; performance-based online and mobile advertising and marketing services, namely, lead generation and customer acquisition; advertising and marketing consultancy, namely, consulting services related to placement and monetization of digital advertising content through online and mobile networks and consumer promotions; providing marketing consulting in the field of social media; mobile ad serving, namely, placing advertisements on websites for publishers and content owners using specialized computer software. Computer services for use in business and consumer applications for risk management and consumer marketing, namely, for use in information and database management, information processing, compiling marketing demographics and information for online and performance-based advertising and marketing services, lead generation and customer acquisition, and collection, structuring, fusing, storing and sharing of data and information with governmental, business and other organizations for risk management; computer services, namely, acting as an application service provider in the field of knowledge management to host computer application software for the collection, organizing, modifying, book marking, transmission, storage and sharing of data and information.


Au cours de l'année 2016, Winncare a réalisé avec succès, au sein de Winncare Nordic, l'intégration des deux acquisitions danoises, Borringia et Ergolet, respectivement positionnées sur les équipements d'hygiène et les systèmes de transfert à destination des hôpitaux, maisons de retraite médicalisées et des structures de maintien à domicile. La Société, avec le soutien de son actionnaire majoritaire, entend poursuivre sa croissance par l'acquisition en France et en Europe de cibles dans le domaine de la prise en charge des personnes en perte d'autonomie pour conforter sa place d'acteur de référence sur ce marché en croissance. Marco de Alfaro, co-dirigeant du comité d'investissement de l'IDI et président du comité de surveillance de Winncare, précise : « Ce refinancement rapide, deux ans et demi après l'opération d'origine, a été rendu possible par l'excellente performance de Winncare : le Groupe s'est rapidement désendetté et les build-ups réalisés en 2015 donnent déjà d'excellents résultats. Nous sommes très heureux de pouvoir continuer à accompagner le management dans ses futures décisions stratégiques et ses besoins de financement.» Groupe Winncare SAS est le leader français dans la conception, la fabrication et la distribution des équipements médicaux utilisés dans la prise en charge des personnes âgées en perte d'autonomie. Le Groupe a enregistré un chiffre d'affaires de l'ordre de 50 millions d'euros sur l'exercice précédent. Winncare est détenu majoritairement par la société d'investissement IDI. Le Groupe Winncare, qui connait une croissance soutenue, développe, fabrique et distribue une large gamme de produits allant des SAPTE aux gammes de levages et de positionnement des patients en passant par les lits médicalisés et le mobilier à destination des hôpitaux, EHPAD et structures de maintien à domicile. L'activité industrielle est organisée autour de 6 sites en France, Espagne, Tunisie, Danemark et Pologne.


Low H.,IDI Inc | Hoang A.,IDI Inc | Sviridov D.,IDI Inc
Journal of Visualized Experiments | Year: 2012

Cholesterol content of cells must be maintained within the very tight limits, too much or too little cholesterol in a cell results in disruption of cellular membranes, apoptosis and necrosis. Cells can source cholesterol from intracellular synthesis and from plasma lipoproteins, both sources are sufficient to fully satisfy cells' requirements for cholesterol. The processes of cholesterol synthesis and uptake are tightly regulated and deficiencies of cholesterol are rare. Excessive cholesterol is more common problem. With the exception of hepatocytes and to some degree adrenocortical cells, cells are unable to degrade cholesterol. Cells have two options to reduce their cholesterol content: to convert cholesterol into cholesteryl esters, an option with limited capacity as overloading cells with cholesteryl esters is also toxic, and cholesterol efflux, an option with potentially unlimited capacity. Cholesterol efflux is a specific process that is regulated by a number of intracellular transporters, such as ATP binding cassette transporter proteins A1 (ABCA1) and G1 (ABCG1) and scavenger receptor type B1. The natural acceptor of cholesterol in plasma is high density lipoprotein (HDL) and apolipoprotein A-I. The cholesterol efflux assay is designed to quantitate the rate of cholesterol efflux from cultured cells. It measures the capacity of cells to maintain cholesterol efflux and/or the capacity of plasma acceptors to accept cholesterol released from cells. The assay consists of the following steps. Step 1: labelling cellular cholesterol by adding labelled cholesterol to serum-containing medium and incubating with cells for 24-48 h. This step may be combined with loading of cells with cholesterol. Step 2: incubation of cells in serum-free medium to equilibrate labelled cholesterol among all intracellular cholesterol pools. This stage may be combined with activation of cellular cholesterol transporters. Step 3: incubation of cells with extracellular acceptor and quantitation of movement of labelled cholesterol from cells to the acceptor. If cholesterol precursors were used to label newly synthesized cholesterol, a fourth step, purification of cholesterol, may be required. The assay delivers the following information: (i) how a particular treatment (a mutation, a knock-down, an overexpression or a treatment) affects the capacity of cell to efflux cholesterol and (ii) how the capacity of plasma acceptors to accept cholesterol is affected by a disease or a treatment. This method is often used in context of cardiovascular research, metabolic and neurodegenerative disorders, infectious and reproductive diseases. © 2012 Journal of Visualized Experiments.


Mukhamedova N.,IDI Inc
Arteriosclerosis, Thrombosis, and Vascular Biology | Year: 2016

OBJECTIVE—: ABCA1 (ATP-binding cassette transporter A1) is the principal protein responsible for cellular cholesterol efflux. Abundance and functionality of ABCA1 is regulated both transcriptionally and post-translationally, with endocytosis of ABCA1 being an important element of post-translational regulation. Functional ABCA1 resides on the plasma membrane but can be internalized and either degraded or recycled back to the plasma membrane. The interaction between the degradative and recycling pathways determines the abundance of ABCA1 and may contribute to the efflux of intracellular cholesterol. APPROACH AND RESULTS—: Here, we show that the principal pathway responsible for the internalization of ABCA1 leading to its degradation in macrophages is ARF6-dependent endocytic pathway. This pathway was predominant in the regulation of ABCA1 abundance and efflux of plasma membrane cholesterol. Conversely, the efflux of intracellular cholesterol was predominantly controlled by ARF6-independent pathways, and inhibition of ARF6 shifted ABCA1 into recycling endosomes enhancing efflux of intracellular cholesterol. CONCLUSIONS—: We conclude that ARF6-dependent pathway is the predominant route responsible for the ABCA1 internalization and degradation, whereas ARF6-independent endocytic pathways may contribute to ABCA1 recycling and efflux of intracellular cholesterol. © 2016 American Heart Association, Inc.


The aim of this study was to evaluate the risk of anxiety and depression among student nurses. If not recognized, this risk can adversely affect student health and learning and the quality of patient care. The study was performed through administration of the twelve-item General Health Questionnaire (GHQ-12) to nursing students attending two universities in Rome (Italy). Forty-seven percent of students attending University A and 38% attending University B were found to be at risk. The risk of anxiety and depression was found to be higher in females with respect to males. In both universities, a higher risk was found in those students who were dissatisfied with their academic grades (University A: p £ 0.001, University B: p = 0.03), or with their family's economic situation (A and B £ p = 0.001), and in those who reported stressful events (A: p = 0.036; B: p = 0.02). Regardless of the university, what emerges is a picture of fragile students with female students showing a greater fragility.


Patent
IDI Inc | Date: 2013-09-03

Disclosed is a system for attenuating x-rays. The disclosed devise utilizes a copper barrier having a minimum total thickness of at least 0.12 mm. The device can be utilized as part of a collimator and/or as part of a masking wall.


Trademark
IDI Inc | Date: 2016-06-17

Computer software for use in business and consumer applications for risk management and consumer marketing, namely, for use in information and database management, information processing, compiling marketing demographics and information for online and performance-based advertising and marketing services, lead generation and customer acquisition, and collection, structuring, fusing, storing and sharing of data and information with governmental, business and other organizations for risk management. Online advertising and marketing services; performance-based online and mobile advertising and marketing services; performance-based online and mobile advertising and marketing services, namely, lead generation and customer acquisition; advertising and marketing consultancy, namely, consulting services related to placement and monetization of digital advertising content through online and mobile networks and consumer promotions; providing marketing consulting in the field of social media; mobile ad serving, namely, placing advertisements on websites for publishers and content owners using specialized computer software. Computer services for use in business and consumer applications for risk management and consumer marketing, namely, for use in information and database management, information processing, compiling marketing demographics and information for online and performance-based advertising and marketing services, lead generation and customer acquisition, and collection, structuring, fusing, storing and sharing of data and information with governmental, business and other organizations for risk management; computer services, namely, acting as an application service provider in the field of knowledge management to host computer application software for the collection, organizing, modifying, book marking, transmission, storage and sharing of data and information.


News Article | December 2, 2016
Site: globenewswire.com


News Article | November 8, 2016
Site: globenewswire.com

Loading IDI Inc collaborators
Loading IDI Inc collaborators